4.7 Article

PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 215, 期 12, 页码 3165-3179

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20172018

关键词

-

资金

  1. Public Health Service (PHS) [AI126845, AI095730]
  2. University of Pittsburgh
  3. PHS grant [AI103022, S10OD011925]
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103022, R21AI095730, R21AI126845] Funding Source: NIH RePORTER
  5. OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011925] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of Listeria monocytogenes infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据